Document › Details

BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv.

Organisations Organisation BioLineRx Ltd. (Nasdaq: BLRX, TASE: BLRX)
  Group BioLineRx (Group)
  Organisation 2 LifeSci Advisors LLC
  Group LifeSci (Group)
Products Product BL-8040 (BioLineRx)
  Product 2 AGI-134 (Agalimmune)
Person Person Serlin, Philip A. (BioLineRx 201610– CEO joined 2009 as CFO + COO before Kayote Networks + Tescom Software)

Record changed: 2019-08-07


Picture [LSUK] – The Business Web Portal 650x99px

More documents for BioLineRx (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] – Putting Information into Context 600x60px

» top